- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04298164
Evaluating the Effectiveness of an Acceptance and Commitment Therapy-based Group Intervention for Parents of Children With a Diagnosis of Autism Spectrum Disorder
April 30, 2021 updated by: University College Dublin
Evaluating the Effectiveness of an Acceptance and Commitment Therapy-based Group Intervention for Parents of Children With a Diagnosis of Autism Spectrum Disorder Attending a Psychological Service
This study is being conducted to look at whether a group programme designed for parents of children with a diagnosis of Autism is effective.
The programme is called The START Programme ©- as it aims to provide a Supportive and Therapeutic environment to help parents gain Acceptance and reach Resolution so that they can Take action to live more consistently with their values.
The programme was developed by two psychologists in Longford/Westmeath, Ireland, Dr. Michelle Howard and Kara McDermott in 2013, because they identified a lack of therapeutic support for such parents.
The programme draws on research and theory from a branch of therapy called Acceptance and Commitment Therapy, as well as some other psychological techniques.
Individuals who agree to participate in the research will be assigned at random to the intervention or to a treatment as usual control condition.
They will be asked to fill out 4 questionnaires, on 3 different occasions, with a 7 week gap between the first time and second time, and a 3 month gap between the second and third time.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
56
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Donegal, Ireland
- HSE Donegal
-
Longford, Ireland
- HSE Longford/Westmeath
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants must be adults over the age of 18 with the capacity to provide informed consent who are willing to take part in all aspects of the study
- They must have at least 1 child with a diagnosed autism spectrum disorder who is linked in with one of the psychology service sites involved in the study.
- They must not have completed the START programme before, or be concurrently attending another group based parental intervention.
Exclusion Criteria:
- Individuals who are under the age of 18, or who unable or unwilling to provide informed consent for all aspects of the study will be not included.
- Individuals who are receiving other current group based parental interventions will not be included.
- Couples may not attend the programme together, as outlined by the Psychologists who developed the programme.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention group
Group that receives the intervention
|
Acceptance and Commitment Therapy based programme for parents of children with Autism
|
|
ACTIVE_COMPARATOR: Control group
Group that receives treatment as usual
|
Treatment as usual in outpatient within outpatient psychology services
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in psychological flexibility
Time Frame: Measured before first session of programme (Week 1), at the final session of the programme (Week 7), and at 3 month follow up (12 Weeks after Week 7)
|
Measured using the Comprehensive assessment of Acceptance and Commitment Therapy Processes (CompACT)
|
Measured before first session of programme (Week 1), at the final session of the programme (Week 7), and at 3 month follow up (12 Weeks after Week 7)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parenting stress
Time Frame: Measured before first session of programme (Week 1), at the final session of the programme (Week 7), and at 3 month follow up (12 Weeks after Week 7)
|
Measured using The Autism Parenting Stress Index
|
Measured before first session of programme (Week 1), at the final session of the programme (Week 7), and at 3 month follow up (12 Weeks after Week 7)
|
|
Mental wellbeing
Time Frame: Measured before first session of programme (Week 1), at the final session of the programme (Week 7), and at 3 month follow up (12 Weeks after Week 7)
|
Measured using The Warwick-Edinburgh Mental Wellbeing Scales (WEMWBS)
|
Measured before first session of programme (Week 1), at the final session of the programme (Week 7), and at 3 month follow up (12 Weeks after Week 7)
|
|
Parent relationship
Time Frame: Measured before first session of programme (Week 1), at the final session of the programme (Week 7), and at 3 month follow up (12 Weeks after Week 7)
|
Parent Problem Checklist (PPC)
|
Measured before first session of programme (Week 1), at the final session of the programme (Week 7), and at 3 month follow up (12 Weeks after Week 7)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 25, 2019
Primary Completion (ACTUAL)
March 30, 2021
Study Completion (ACTUAL)
March 30, 2021
Study Registration Dates
First Submitted
February 24, 2020
First Submitted That Met QC Criteria
March 4, 2020
First Posted (ACTUAL)
March 6, 2020
Study Record Updates
Last Update Posted (ACTUAL)
May 3, 2021
Last Update Submitted That Met QC Criteria
April 30, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- START1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
Healing Hope InternationalKurve Technology Inc.Enrolling by invitationNeurodevelopmental Disorders | Autism Spectrum Disorder | Autistic Disorder | Autism Spectrum Disorder (ASD) | Autistic Disorders Spectrum | Autism Spectrum Disorder High-Functioning | Autism Spectrum Disorder With Impaired Functional Language | Autistic Disorder of Childhood Onset With Full Syndrome and other conditionsUnited States
Clinical Trials on START programme
-
The First Affiliated Hospital of Dalian Medical...Fudan University; Beijing Friendship Hospital; Chinese PLA General Hospital; First... and other collaboratorsCompletedChronic Kidney DiseaseChina
-
University of Alabama at BirminghamCompletedPediatric CancerUnited States
-
University of ArizonaNational Cancer Institute (NCI); Michigan State UniversityCompleted
-
M.D. Anderson Cancer CenterRecruitingDyspneaUnited States
-
Revmatismesykehuset ASSouth-Eastern Norway Regional Health AuthorityCompletedMusculoskeletal Diseases or ConditionsNorway
-
University of California, San FranciscoCompleted
-
University of MiamiCompletedMental Health Wellness 1United States
-
Karolinska InstitutetCompletedOut-Of-Hospital Cardiac Arrest | Cardiac Arrest, SuddenSweden
-
University of California, San FranciscoWithdrawnMorbid Obesity